JC
TMO icon

Jacobs & Co’s Thermo Fisher Scientific TMO Stock Holding History

Jacobs & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.11M Sell
16,176
-1,072
-6% -$515K 0.7% 53
2026
Q1 		$8.48M Buy
17,248
+13
+0.1% +$7.05K 0.84% 47
2025
Q4 		$9.99M Sell
17,235
-493
-3% -$279K 0.94% 42
2025
Q3 		$8.6M Buy
17,728
+221
+1% +$103K 0.82% 52
2025
Q2 		$7.1M Buy
17,507
+2,090
+14% +$874K 0.7% 59
2025
Q1 		$7.67M Buy
15,417
+211
+1% +$114K 0.82% 51
2024
Q4 		$7.91M Buy
15,206
+1,473
+11% +$810K 0.8% 51
2024
Q3 		$8.49M Sell
13,733
-161
-1% -$95.3K 0.85% 49
2024
Q2 		$7.68M Sell
13,894
-194
-1% -$111K 0.81% 51
2024
Q1 		$8.19M Sell
14,088
-78
-0.6% -$43.8K 0.87% 49
2023
Q4 		$7.52M Buy
14,166
+2,460
+21% +$1.19M 0.85% 51
2023
Q3 		$5.92M Buy
11,706
+4,977
+74% +$2.65M 0.74% 56
2023
Q2 		$3.51M Buy
6,729
+6,017
+845% +$3.25M 0.42% 74
2023
Q1 		$410K Hold
712
– – 0.05% 100
2022
Q4 		$392K Sell
712
-25
-3% -$13.2K 0.05% 102
2022
Q3 		$373K Hold
737
– – 0.05% 99
2022
Q2 		$400K Hold
737
– – 0.05% 95
2022
Q1 		$435K Hold
737
– – 0.05% 97
2021
Q4 		$491K Hold
737
– – 0.05% 97
2021
Q3 		$421K Hold
737
– – 0.05% 98
2021
Q2 		$371K Hold
737
– – 0.04% 99
2021
Q1 		$336K Sell
737
-50
-6% -$23.9K 0.04% 100
2020
Q4 		$366K Buy
787
+50
+7% +$23.4K 0.05% 96
2020
Q3 		$325K Hold
737
– – 0.05% 96
2020
Q2 		$267K Hold
737
– – 0.04% 101
2020
Q1 		$209K Hold
737
– – 0.04% 120
2019
Q4 		$239K Sell
737
-13
-2% -$3.94K 0.04% 121
2019
Q3 		$218K Hold
750
– – 0.04% 130
2019
Q2 		$220K Hold
750
– – 0.04% 134
2019
Q1 		$205K Buy
+750
New +$187K 0.03% 131

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Jacobs & Co's TMO Position: Q2 2026 in Review

Jacobs & Co reduced its Thermo Fisher Scientific (TMO) stake by 6.2% in Q2 2026, selling an estimated $515K and leaving 16,176 shares worth $8.11M. The position accounts for 0.7% of the portfolio, ranked #53.

Jacobs & Co first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $9.99M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Jacobs & Co held 16,176 shares of Thermo Fisher Scientific worth $8.11M as of Q2 2026.
  • Jacobs & Co sold 1,072 Thermo Fisher Scientific shares in Q2 2026, an estimated $515K.
  • Thermo Fisher Scientific made up 0.7% of Jacobs & Co's portfolio in Q2 2026, its #53 holding.
  • Jacobs & Co first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • Jacobs & Co's Thermo Fisher Scientific position peaked at $9.99M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.